Literature DB >> 14514807

Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery.

Shiro Miyayama1, Osamu Matsui, Hiroto Nishida, Sanae Yamamori, Tetsuya Minami, Rieko Shinmura, Kazuto Kozaka, Kazuo Notsumata, Daisyu Toya, Nobuyoshi Tanaka, Takeshi Mitsui, Hiroshi Nishijima.   

Abstract

PURPOSE: To evaluate the safety, technical success rate, and effectiveness of transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC) fed by the cystic artery.
MATERIALS AND METHODS: Treatment of 27 tumors in 25 patients fed by the cystic artery was attempted with TACE. Twenty-two patients had previously undergone one to eight TACE sessions (mean, four sessions), and the duration after initiation of treatment of HCC was 4-69 months (mean, 24). In three patients, parasitization of the cystic artery was revealed at initial angiography. TACE was performed only when the microcatheter could be inserted into the tumor feeding branch and the stain of the gallbladder wall disappeared. The therapeutic effects and complications were retrospectively analyzed.
RESULTS: Seventeen tumors were completely fed by the cystic artery and 10 were fed by both the hepatic artery and cystic artery. Attenuation or occlusion of the hepatic artery was observed in 56%. The tumor feeding branch arising from the cystic artery could be successfully embolized in 18 tumors (67%) of 16 patients without severe complications. Adequate iodized oil accumulation was achieved in 14 tumors (52%) of 12 patients. Percutaneous therapy (n = 7), radiation (n = 4), and TACE after cholecystectomy (n = 1) were added for tumors with incomplete or unsuccessful TACE. Local progression was observed in three (21%) of 14 tumors treated by TACE alone during a mean follow-up period of 18 months.
CONCLUSION: TACE via the cystic artery was safe and technically possible in 67% of patients. If adequate iodized oil accumulation is obtained, which was only achieved in 52% of patients, sufficient therapeutic effect may be expected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14514807     DOI: 10.1097/01.rvi.0000086534.86489.10

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  10 in total

1.  Hepatic arterial embolization complicated by acute cholecystitis.

Authors:  Rajesh P Shah; Karen T Brown
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration.

Authors:  Dexiao Huang; Yong Chen; Qingle Zeng; Jianbo Zhao; Xizhong Wu; Renhua Wu; Yanhao Li
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

3.  Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma.

Authors:  Yong-Li Wang; Ming-Hua Li; Ying-Sheng Cheng; Hai-Bing Shi; Hai-Lun Fan
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

4.  The usefulness of cone-beam computed tomography during chemoembolization of hepatocellular carcinomas fed exclusively by the cystic artery.

Authors:  Mitsuhiro Kinoshita; Katsuya Takechi; Seiji Iwamoto; Shoichiro Takao; Ryozo Shirono; Masafumi Harada
Journal:  Jpn J Radiol       Date:  2016-09-21       Impact factor: 2.374

5.  Establishment and characterization of McA-RH7777 cells using virus-mediated stable overexpression of enhanced green fluorescent protein.

Authors:  Wei Zhang; Sheng Qian; Guowei Yang; Liang Zhu; Bo Zhou; Xudong Qu; Zhiping Yan; Rong Liu; Jianhua Wang
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

6.  Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.

Authors:  Justin P McWilliams; Stephen T Kee; Christopher T Loh; Edward W Lee; David M Liu
Journal:  Cardiovasc Intervent Radiol       Date:  2010-11-11       Impact factor: 2.740

7.  Hepatocellular carcinomas smaller than 4 cm supplied by the intercostal artery: can we predict which intercostal artery supplies the tumor?

Authors:  Saebeom Hur; Hyo-Cheol Kim; Jin Wook Chung; Min-Uk Kim; Ji Dae Kim; Gyoung Min Kim; In Joon Lee; Young Il Kim; Hwan Jun Jae; Jae Hyung Park
Journal:  Korean J Radiol       Date:  2011-09-27       Impact factor: 3.500

8.  Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients.

Authors:  Jin Wook Chung; Hyo-Cheol Kim; Jung-Hwan Yoon; Hyo-Suk Lee; Hwan Jun Jae; Whal Lee; Jae Hyung Park
Journal:  Korean J Radiol       Date:  2006 Oct-Dec       Impact factor: 3.500

9.  Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results.

Authors:  Shibing Hu; Jianfei Tu; Zhongzhi Jia; Yuanquan Huang; Guomin Jiang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 10.  The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.

Authors:  Sung Wook Shin
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.